Skip to main content
. 2024 Jun 7;14(6):609. doi: 10.3390/jpm14060609

Table 2.

Statistics of comparisons between groups defined by the presence/absence of objective binge-eating episodes or purging behaviors.

Variables Objective Binge-Eating Episodes (Yes vs. No) Purging Behaviors (Yes vs. No)
t or χ2 p q-FDR t or χ2 p q-FDR
Age 0.095 <0.001 0.004 2.165 0.099 0.040
Gender Male 1.893 0.169 0.043 0.397 0.529 0.061
Female
Education (years) 0.285 0.360 0.054 1.216 0.228 0.052
Work Unemployed 1.328 0.580 0.074 7.072 0.029 0.016
Student
Employed
Marital Status
Missing n = 4
Single/separated 0.038 0.846 0.093 0.201 0.654 0.072
Married
Smoke
Missing n = 3
No 0.051 0.822 0.090 0.432 0.511 0.058
Yes
Number of cigarettes/day
Missing n = 3
0.046 0.873 0.088 1.061 0.030 0.032
Dietary habits
Missing n = 4
Omnivorous 6.574 0.087 0.032 2.820 0.420 0.051
Vegetarian
Hyperproteic
Age at onset 1.151 0.808 0.085 2.721 0.015 0.024
Diagnosis AN 26.693 <0.001 0.002 10.186 0.017 0.015
BN
BED
OSFED
Duration of illness (months) 2.162 0.019 0.031 0.842 0.273 0.056
DUI (months) 0.823 0.114 0.038 1.672 0.019 0.028
BMI 4.422 0.245 0.046 2.173 <0.001 0.004
Family history of mental disorders
Missing n = 2
No 0.993 0.319 0.061 0.214 0.644 0.070
Yes
Type of family history
Missing n = 2
None 5.619 0.229 0.052 4.016 0.404 0.048
Major depression
Anxiety disorders
SUD
EDs
Obstetrical complications None 3.715 0.294 0.058 4.003 0.261 0.032
Low weight (<2500 g)
Premature (<32 weeks)
Cord hypoxia
Lifetime substance use disorders
Missing n = 1
No 1.389 0.239 0.053 1.745 0.187 0.028
Yes
Main type of substance use disorder
Missing n = 1
None 6.597 0.159 0.040 4.950 0.292 0.037
Cannabinoids
Opioids
Cocaine
Alcohol
Poly-substance use disorders
Missing n = 1
No 3.704 0.054 0.026 0.003 0.954 0.094
Yes
Psychiatric comorbidity
Missing n = 2
No 5.628 0.018 0.012 0.783 0.376 0.045
Yes
Type of psychiatric comorbidity
Missing n = 2
None 11.642 0.009 0.007 3.035 0.386 0.046
Major depression
Anxiety disorders
OCD
Multiple psychiatric comorbidity
Missing n = 2
No - - - - - -
Lifetime psychotic symptoms
Missing n = 1
No - - - - - -
Personality disorder
Missing n = 6
No 6.016 0.014 0.010 0.621 0.431 0.053
Yes
Type of personality disorder
Missing n = 6
None 11.042 0.026 0.018 5.108 0.276 0.035
Schizotypic
Borderline
Hystrionic
Obsessive–compulsive
Lifetime suicide attempts No - - - - - -
Lifetime hospitalizations
Missing n = 4
No 0.330 0.566 0.075 1.084 0.298 0.039
Yes
Number of hospitalizations 1.301 0.012 0.023 0.536 0.385 0.060
Current pharmacological treatment No 2.350 0.125 0.037 0.047 0.828 0.084
Yes
Main current pharmacological treatment
Missing n = 1
None 7.804 0.453 0.068 5.623 0.689 0.075
Sertraline
Escitalopram
Vortioxetine
Olanzapine
Benzodiazepines
Pregabalin
Fluoxetine
Melatonine
Current poly-therapy
Missing n = 1
No 2.568 0.109 0.034 0.321 0.571 0.064
Yes
Current psychotherapy
Missing n = 1
No 0.496 0.481 0.069 0.024 0.877 0.089
Yes
Pharmacotherapy prescription No 7.864 0.005 0.005 0.158 0.691 0.076
Yes
Type of pharmacotherapy prescription
Missing n = 2
None 12.704 0.048 0.024 3.474 0.747 0.080
Sertraline
Escitalopram
Vortioxetine
Zolpidem
Benzodiazepine
Pregabalin
Duration of the last pharmacological treatment (months) 3.189 <0.001 0.011 0.311 0.489 0.076
Medical comorbidity
Missing n = 3
No 1.002 0.317 0.061 0.674 0.412 0.050
Yes
Thyroid disorders
Missing n = 3
No 1.559 0.212 0.047 1.110 0.292 0.036
Yes
Hypercholesterolemia
Missing n = 2
No 1.758 0.185 0.045 1.063 0.302 0.040
Yes
Diabetes
Missing n = 1
No - - - - - -
Multiple medical comorbidities
Missing n = 1
No 1.277 0.258 0.057 1.923 0.166 0.024
Yes
Amenorrhea
Missing n = 3
No 5.032 0.081 0.030 7.821 0.020 0.015
Yes
Estroprogestinic therapy
Self-induced vomiting No 4.703 0.030 0.019 20.433 <0.001 0.003
Yes
Number of episodes of self-induced vomiting acts in the last month 2.675 <0.001 0.015 2.380 <0.001 0.012
Laxative misuse No 0.242 0.623 0.078 10.508 0.001 0.009
Yes
Number of episodes of laxative use in the last month 0.346 0.612 0.065 2.014 <0.001 0.016
Diuretic misuse No 0.145 0.704 0.084 2.002 0.157 0.023
Yes
Number of episodes of diuretic use in the last month 0.424 0.398 0.058 1.414 0.003 0.020
Compulsive exercise No 0.011 0.917 0.097 16.776 <0.001 0.006
Yes
Number of episodes of compulsive exercises in the last month 1.212 0.004 0.019 4.084 <0.001 0.008
Number of objective binge-eating episodes in the last month 5.895 <0.001 0.008 0.700 0.180 0.044
Number of subjective binge-eating episodes in the last month 1.296 0.012 0.027 0.470 0.216 0.048
Number of objective overeatings in the last month 1.162 0.026 0.035 0.435 0.395 0.068
Dietary restraint (EDE subscale) 0.400 0.777 0.081 0.443 0.558 0.080
Eating concern (EDE subscale) 1.360 0.651 0.069 0.475 0.453 0.072
Body shape concern (EDE subscale) 2.146 0.774 0.077 0.013 0.874 0.100
Weight concern (EDE subscale) 2.297 0.149 0.042 0.397 0.799 0.092
EDE global score 1.295 0.533 0.061 0.189 0.662 0.084
HAM-D 1.449 0.302 0.050 0.502 0.870 0.096
HAM-A 2.122 0.966 0.100 0.201 0.754 0.088
MADRS 1.125 0.754 0.073 0.491 0.385 0.064
CGI-S 0.261 0.923 0.096 1.531 0.037 0.036

Legend: AN = anorexia nervosa; BED = binge-eating disorder; BMI = body mass index; BN = bulimia nervosa; CGI-S = Clinical Global Impression-severity subscale; χ2 = chi-square; DUI = duration of untreated illness; ED = eating disorder; EDE = Eating Disorder Examination; HAM-A = Hamilton Anxiety Rating Scale; HAM-D = Hamilton Depression Rating Scale; MADRS = Montgomery and Åsberg Depression Rating Scale; OCD = obsessive–compulsive disorder; OSFED = otherwise specified feeding and eating disorders; p = p-value; SUD = substance use disorder; t = Student’s t-test. In bold, statistically significant p-value (≤0.05). For the total, sample mean and ±standard deviations (into bracket) are reported for continuous variables and frequencies with percentages (into brackets) for qualitative variables. We have reported in bold statistically significant p and q-FDR values resulting from multiple comparison methods based on Benjamini–Hochberg False Discovery Rate.